癌用バイオマーカーの世界市場レポート2020

• 英文タイトル：Global Cancer Biomarkers Sales Market Report 2020

• レポートコード：20QY06-04966 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：化学・材料

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、癌用バイオマーカーのグローバル市場について種類別（タンパク質バイオマーカー、遺伝子バイオマーカー、その他）、用途別（乳癌、肺癌、大腸癌、黒色腫、血液癌、前立腺癌、卵巣癌、胃癌、肝臓癌）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・癌用バイオマーカー市場の概要 ・世界の主要地域別癌用バイオマーカー市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の癌用バイオマーカー市場規模2015-2026：種類別（タンパク質バイオマーカー、遺伝子バイオマーカー、その他） ・世界の癌用バイオマーカー市場規模2015-2026：用途別（乳癌、肺癌、大腸癌、黒色腫、血液癌、前立腺癌、卵巣癌、胃癌、肝臓癌） ・癌用バイオマーカーの北米市場規模2015-2020 ・癌用バイオマーカーのヨーロッパ市場規模2015-2020 ・癌用バイオマーカーの中国市場規模2015-2020 ・癌用バイオマーカーの日本市場規模2015-2020 ・癌用バイオマーカーの東南アジア市場規模2015-2020 ・癌用バイオマーカーのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Abbott Laboratories、、Thermo Fisher Scientific、、F. Hoffmann-La Roche Ltd、、Illumina,Inc.、、Agilent Technologies、、Qiagen NV、、Merck & Co.、、Hologic,Inc.、、Novartis AG、、BioMerieux SA、、Genomic Health、、Affymetrix、、Roche Diagnostics Ltd.、） ・癌用バイオマーカーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・癌用バイオマーカーの市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Cancer Biomarkers Market

The global Cancer Biomarkers market was valued at US$ 11710 million in 2019 and will reach US$ 18790 million by the end of 2026, growing at a CAGR of 6.9% during 2020-2026.

Global Cancer Biomarkers Scope and Market Size

The global Cancer Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Cancer Biomarkers market is segmented into

Protein Biomarkers

Genetic Biomarkers

Others

Segment by Application, the Cancer Biomarkers market is segmented into

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Blood Cancer

Prostate Cancer

Ovarian Cancer

Stomach Cancer

Liver Cancer

The Cancer Biomarkers market is analysed and market size information is provided by regions (countries). Segment by Application, the Cancer Biomarkers market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Cancer Biomarkers Market Share Analysis

Cancer Biomarkers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Biomarkers business, the date to enter into the Cancer Biomarkers market, Cancer Biomarkers product introduction, recent developments, etc.

The major vendors covered:

Abbott Laboratories

Thermo Fisher Scientific

F. Hoffmann-La Roche Ltd

Illumina,Inc.

Agilent Technologies

Qiagen NV

Merck & Co.

Hologic,Inc.

Novartis AG

BioMerieux SA

Genomic Health

Affymetrix

Roche Diagnostics Ltd.

レポート目次

---

Table of Contents

1 Cancer Biomarkers Market Overview

1.1 Cancer Biomarkers Product Scope

1.2 Cancer Biomarkers Segment by Type

1.2.1 Global Cancer Biomarkers Sales by Type (2020-2026)

1.2.2 Protein Biomarkers

1.2.3 Genetic Biomarkers

1.2.4 Others

1.3 Cancer Biomarkers Segment by Application

1.3.1 Global Cancer Biomarkers Sales Comparison by Application (2020-2026)

1.3.2 Breast Cancer

1.3.3 Lung Cancer

1.3.4 Colorectal Cancer

1.3.5 Melanoma

1.3.6 Blood Cancer

1.3.7 Prostate Cancer

1.3.8 Ovarian Cancer

1.3.9 Stomach Cancer

1.3.10 Liver Cancer

1.4 Cancer Biomarkers Market Estimates and Forecasts (2015-2026)

1.4.1 Global Cancer Biomarkers Sales Growth Rate (2015-2026)

1.4.2 Global Cancer Biomarkers Revenue and Growth Rate (2015-2026)

1.4.3 Global Cancer Biomarkers Price Trends (2015-2026)

2 Cancer Biomarkers Estimate and Forecast by Region

2.1 Global Cancer Biomarkers Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Cancer Biomarkers Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Cancer Biomarkers Sales Market Share by Region (2015-2020)

2.2.2 Global Cancer Biomarkers Revenue Market Share by Region (2015-2020)

2.3 Global Cancer Biomarkers Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Cancer Biomarkers Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Cancer Biomarkers Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Cancer Biomarkers Estimates and Projections (2015-2026)

2.4.2 Europe Cancer Biomarkers Estimates and Projections (2015-2026)

2.4.3 China Cancer Biomarkers Estimates and Projections (2015-2026)

2.4.4 Japan Cancer Biomarkers Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Cancer Biomarkers Estimates and Projections (2015-2026)

2.4.6 India Cancer Biomarkers Estimates and Projections (2015-2026)

3 Global Cancer Biomarkers Competition Landscape by Players

3.1 Global Top Cancer Biomarkers Players by Sales (2015-2020)

3.2 Global Top Cancer Biomarkers Players by Revenue (2015-2020)

3.3 Global Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biomarkers as of 2019)

3.4 Global Cancer Biomarkers Average Price by Company (2015-2020)

3.5 Manufacturers Cancer Biomarkers Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Cancer Biomarkers Players (Opinion Leaders)

4 Global Cancer Biomarkers Market Size by Type

4.1 Global Cancer Biomarkers Historic Market Review by Type (2015-2020)

4.1.1 Global Cancer Biomarkers Sales Market Share by Type (2015-2020)

4.1.2 Global Cancer Biomarkers Revenue Market Share by Type (2015-2020)

4.1.3 Global Cancer Biomarkers Price by Type (2014-2020)

4.2 Global Cancer Biomarkers Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Cancer Biomarkers Sales Forecast by Type (2021-2026)

4.2.2 Global Cancer Biomarkers Revenue Forecast by Type (2021-2026)

4.2.3 Global Cancer Biomarkers Price Forecast by Type (2021-2026)

5 Global Cancer Biomarkers Market Size by Application

5.1 Global Cancer Biomarkers Historic Market Review by Application (2015-2020)

5.1.1 Global Cancer Biomarkers Sales Market Share by Application (2015-2020)

5.1.2 Global Cancer Biomarkers Revenue Market Share by Application (2015-2020)

5.1.3 Global Cancer Biomarkers Price by Application (2015-2020)

5.2 Global Cancer Biomarkers Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Cancer Biomarkers Sales Forecast by Application (2021-2026)

5.2.2 Global Cancer Biomarkers Revenue Forecast by Application (2021-2026)

5.2.3 Global Cancer Biomarkers Price Forecast by Application (2021-2026)

3 North America Cancer Biomarkers Market Facts & Figures

3.2 North America Cancer Biomarkers Sales Market Share by Company (2015-2020)

3.3 North America Cancer Biomarkers Sales Market Share by Type (2015-2020)

3.4 North America Cancer Biomarkers Sales Market Share by Application (2015-2020)

4 Europe Cancer Biomarkers Market Facts & Figures

4.2 Europe Cancer Biomarkers Sales Market Share by Company (2015-2020)

4.3 Europe Cancer Biomarkers Sales Market Share by Type (2015-2020)

4.4 Europe Cancer Biomarkers Sales Market Share by Application (2015-2020)

5 China Cancer Biomarkers Market Facts & Figures

5.2 China Cancer Biomarkers Sales Market Share by Company (2015-2020)

5.3 China Cancer Biomarkers Sales Market Share by Type (2015-2020)

5.4 China Cancer Biomarkers Sales Market Share by Application (2015-2020)

6 Japan Cancer Biomarkers Market Facts & Figures

6.2 Japan Cancer Biomarkers Sales Market Share by Company (2015-2020)

6.3 Japan Cancer Biomarkers Sales Market Share by Type (2015-2020)

6.4 Japan Cancer Biomarkers Sales Market Share by Application (2015-2020)

7 Southeast Asia Cancer Biomarkers Market Facts & Figures

7.2 Southeast Asia Cancer Biomarkers Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Cancer Biomarkers Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Cancer Biomarkers Sales Market Share by Application (2015-2020)

8 India Cancer Biomarkers Market Facts & Figures

8.2 India Cancer Biomarkers Sales Market Share by Company (2015-2020)

8.3 India Cancer Biomarkers Sales Market Share by Type (2015-2020)

8.4 India Cancer Biomarkers Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Cancer Biomarkers Business

12.1 Abbott Laboratories

12.1.1 Abbott Laboratories Cancer Biomarkers Corporation Information

12.1.2 Abbott Laboratories Cancer Biomarkers Business Overview and Total Revenue

12.1.3 Abbott Laboratories Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Abbott Laboratories Cancer Biomarkers Products Offered

12.1.5 Abbott Laboratories Recent Development

12.2 Thermo Fisher Scientific

12.2.1 Thermo Fisher Scientific Cancer Biomarkers Corporation Information

12.2.2 Thermo Fisher Scientific Cancer Biomarkers Business Overview and Total Revenue

12.2.3 Thermo Fisher Scientific Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Thermo Fisher Scientific Cancer Biomarkers Products Offered

12.2.5 Thermo Fisher Scientific Recent Development

12.3 F. Hoffmann-La Roche Ltd

12.3.1 F. Hoffmann-La Roche Ltd Cancer Biomarkers Corporation Information

12.3.2 F. Hoffmann-La Roche Ltd Cancer Biomarkers Business Overview and Total Revenue

12.3.3 F. Hoffmann-La Roche Ltd Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.3.4 F. Hoffmann-La Roche Ltd Cancer Biomarkers Products Offered

12.3.5 F. Hoffmann-La Roche Ltd Recent Development

12.4 Illumina,Inc.

12.4.1 Illumina,Inc. Cancer Biomarkers Corporation Information

12.4.2 Illumina,Inc. Cancer Biomarkers Business Overview and Total Revenue

12.4.3 Illumina,Inc. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.4.4 Illumina,Inc. Cancer Biomarkers Products Offered

12.4.5 Illumina,Inc. Recent Development

12.5 Agilent Technologies

12.5.1 Agilent Technologies Cancer Biomarkers Corporation Information

12.5.2 Agilent Technologies Cancer Biomarkers Business Overview and Total Revenue

12.5.3 Agilent Technologies Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Agilent Technologies Cancer Biomarkers Products Offered

12.5.5 Agilent Technologies Recent Development

12.6 Qiagen NV

12.6.1 Qiagen NV Cancer Biomarkers Corporation Information

12.6.2 Qiagen NV Cancer Biomarkers Business Overview and Total Revenue

12.6.3 Qiagen NV Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.6.4 Qiagen NV Cancer Biomarkers Products Offered

12.6.5 Qiagen NV Recent Development

12.7 Merck & Co.

12.7.1 Merck & Co. Cancer Biomarkers Corporation Information

12.7.2 Merck & Co. Cancer Biomarkers Business Overview and Total Revenue

12.7.3 Merck & Co. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.7.4 Merck & Co. Cancer Biomarkers Products Offered

12.7.5 Merck & Co. Recent Development

12.8 Hologic,Inc.

12.8.1 Hologic,Inc. Cancer Biomarkers Corporation Information

12.8.2 Hologic,Inc. Cancer Biomarkers Business Overview and Total Revenue

12.8.3 Hologic,Inc. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.8.4 Hologic,Inc. Cancer Biomarkers Products Offered

12.8.5 Hologic,Inc. Recent Development

12.9 Novartis AG

12.9.1 Novartis AG Cancer Biomarkers Corporation Information

12.9.2 Novartis AG Cancer Biomarkers Business Overview and Total Revenue

12.9.3 Novartis AG Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.9.4 Novartis AG Cancer Biomarkers Products Offered

12.9.5 Novartis AG Recent Development

12.10 BioMerieux SA

12.10.1 BioMerieux SA Cancer Biomarkers Corporation Information

12.10.2 BioMerieux SA Cancer Biomarkers Business Overview and Total Revenue

12.10.3 BioMerieux SA Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.10.4 BioMerieux SA Cancer Biomarkers Products Offered

12.10.5 BioMerieux SA Recent Development

12.11 Genomic Health

12.11.1 Genomic Health Cancer Biomarkers Corporation Information

12.11.2 Genomic Health Cancer Biomarkers Business Overview and Total Revenue

12.11.3 Genomic Health Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.11.4 Genomic Health Cancer Biomarkers Products Offered

12.11.5 Genomic Health Recent Development

12.12 Affymetrix

12.12.1 Affymetrix Cancer Biomarkers Corporation Information

12.12.2 Affymetrix Cancer Biomarkers Business Overview and Total Revenue

12.12.3 Affymetrix Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.12.4 Affymetrix Cancer Biomarkers Products Offered

12.12.5 Affymetrix Recent Development

12.13 Roche Diagnostics Ltd.

12.13.1 Roche Diagnostics Ltd. Cancer Biomarkers Corporation Information

12.13.2 Roche Diagnostics Ltd. Cancer Biomarkers Business Overview and Total Revenue

12.13.3 Roche Diagnostics Ltd. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)

12.13.4 Roche Diagnostics Ltd. Cancer Biomarkers Products Offered

12.13.5 Roche Diagnostics Ltd. Recent Development

13 Cancer Biomarkers Manufacturing Cost Analysis

13.1 Cancer Biomarkers Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Cancer Biomarkers

13.4 Cancer Biomarkers Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Cancer Biomarkers Distributors List

14.3 Cancer Biomarkers Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables



Table 1. Global Cancer Biomarkers Sales (K MT) Growth Rate by Type (2020-2026)

Table 2. Global Cancer Biomarkers Sales (K MT) Comparison by Application (2020-2026)

Table 3. Global Market Cancer Biomarkers Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 4. Global Cancer Biomarkers Sales (K MT) by Region (2015-2020)

Table 5. Global Cancer Biomarkers Sales Market Share by Region (2015-2020)

Table 6. Global Cancer Biomarkers Revenue (US$ Million) Market Share by Region (2015-2020))

Table 7. Global Cancer Biomarkers Revenue Share by Region (2015-2020)

Table 8. Global Cancer Biomarkers Sales (K MT) Forecast by Region (2021-2026)

Table 9. Global Cancer Biomarkers Sales Market Share Forecast by Region (2021-2026)

Table 10. Global Cancer Biomarkers Revenue (US$ Million) Forecast by Region (2021-2026)

Table 11. Global Cancer Biomarkers Revenue Share Forecast by Region (2021-2026)

Table 12. Global Cancer Biomarkers (K MT) of Key Companies (2015-2020)

Table 13. Global Cancer Biomarkers Sales Share by Company (2015-2020)

Table 14. Global Cancer Biomarkers Revenue (US$ Million) by Company (2015-2020)

Table 15. Global Cancer Biomarkers Revenue Share by Company (2015-2020)

Table 16. Global Cancer Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biomarkers as of 2019)

Table 17. Global Cancer Biomarkers Average Price (USD/MT) of Key Company (2015-2020)

Table 18. Manufacturers Cancer Biomarkers Manufacturing Sites and Area Served

Table 19. Manufacturers Cancer Biomarkers Product Type

Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 21. Main Points Interviewed from Key Cancer Biomarkers Players

Table 22. Global Cancer Biomarkers Sales (K MT) by Type (2015-2020)

Table 23. Global Cancer Biomarkers Sales Share by Type (2015-2020)

Table 24. Global Cancer Biomarkers Revenue (US$ Million) Market Share by Type (2015-2020)

Table 25. Global Cancer Biomarkers Price (K MT) by Type (2015-2020)

Table 26. Global Cancer Biomarkers Sales Share by Type (2021-2026)

Table 27. Global Cancer Biomarkers Revenue (US$ Million) Market Share by Type (2021-2026)

Table 28. Global Cancer Biomarkers Revenue Share by Type (2021-2026)

Table 29. Global Cancer Biomarkers Price (K MT) by Type (2021-2026)

Table 30. Global Cancer Biomarkers Sales (K MT) by Application (2015-2020)

Table 31. Global Cancer Biomarkers Sales Share by Application (2015-2020)

Table 32. Global Cancer Biomarkers Revenue (US$ Million) Market Share by Application (2015-2020)

Table 33. Global Cancer Biomarkers Price (K MT) by Application (2015-2020)

Table 34. Global Cancer Biomarkers Sales (K MT) by Application (2021-2026)

Table 35. Global Cancer Biomarkers Sales Share by Application (2021-2026)

Table 36. Global Cancer Biomarkers Revenue (US$ Million) Market Share by Application (2021-2026)

Table 37. Global Cancer Biomarkers Revenue Share by Application (2021-2026)

Table 38. Global Cancer Biomarkers Price (K MT) by Application (2021-2026)

Table 39. United States Cancer Biomarkers Sales (K MT) by Company (2015-2020)

Table 40. United States Cancer Biomarkers Sales Market Share by Company (2015-2020)

Table 41. United States Cancer Biomarkers Sales (K MT) by Type (2015-2020)

Table 42. United States Cancer Biomarkers Sales Market Share by Type (2015-2020)

Table 43. United States Cancer Biomarkers Sales (K MT) by Application (2015-2020)

Table 44. United States Cancer Biomarkers Sales Market Share by Application (2015-2020)

Table 45. Europe Cancer Biomarkers Sales (K MT) by Company (2015-2020)

Table 46. Europe Cancer Biomarkers Sales Market Share by Company (2015-2020)

Table 47. Europe Cancer Biomarkers Sales (K MT) by Type (2015-2020)

Table 48. Europe Cancer Biomarkers Sales Market Share by Type (2015-2020)

Table 49. Europe Cancer Biomarkers Sales (K MT) by Application (2015-2020)

Table 50. Europe Cancer Biomarkers Sales Market Share by Type (2015-2020)

Table 51. China Cancer Biomarkers Sales (K MT) by Company (2015-2020)

Table 52. China Cancer Biomarkers Sales Market Share by Company (2015-2020)

Table 53. China Cancer Biomarkers Sales (K MT) by Type (2015-2020)

Table 54. China Cancer Biomarkers Sales Market Share by Type (2015-2020)

Table 55. China Cancer Biomarkers Sales (K MT) by Application (2015-2020)

Table 56. China Cancer Biomarkers Sales Market Share by Application (2015-2020)

Table 57. Japan Cancer Biomarkers Sales (K MT) by Company (2015-2020)

Table 58. Japan Cancer Biomarkers Sales Market Share by Company (2015-2020)

Table 59. Japan Cancer Biomarkers Sales (K MT) by Type (2015-2020)

Table 60. Japan Cancer Biomarkers Sales Market Share by Type (2015-2020)

Table 61. Japan Cancer Biomarkers Sales (K MT) by Application (2015-2020)

Table 62. Japan Cancer Biomarkers Sales Market Share by Application (2015-2020)

Table 63. Southeast Asia Cancer Biomarkers Sales (K MT) by Company (2015-2020)

Table 64. Southeast Asia Cancer Biomarkers Sales Market Share by Company (2015-2020)

Table 65. Southeast Asia Cancer Biomarkers Sales (K MT) by Type (2015-2020)

Table 66. Southeast Asia Cancer Biomarkers Sales Market Share by Type (2015-2020)

Table 67. Southeast Asia Cancer Biomarkers Sales (K MT) by Type (2015-2020)

Table 68. Southeast Asia Cancer Biomarkers Sales Market Share by Application (2015-2020)

Table 69. India Cancer Biomarkers Sales (K MT) by Company (2015-2020)

Table 70. India Cancer Biomarkers Sales Market Share by Company (2015-2020)

Table 71. India Cancer Biomarkers Sales (K MT) by Type (2015-2020)

Table 72. India Cancer Biomarkers Sales Market Share by Type (2015-2020)

Table 73. India Cancer Biomarkers Sales (K MT) by Application (2015-2020)

Table 74. India Cancer Biomarkers Sales Market Share by Application (2015-2020)

Table 75. Abbott Laboratories Corporation Information

Table 76. Abbott Laboratories Description and Business Overview

Table 77. Abbott Laboratories Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 78. Abbott Laboratories Cancer Biomarkers Product

Table 79. Abbott Laboratories Recent Development

Table 80. Thermo Fisher Scientific Corporation Information

Table 81. Thermo Fisher Scientific Description and Business Overview

Table 82. Thermo Fisher Scientific Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 83. Thermo Fisher Scientific Cancer Biomarkers Product

Table 84. Thermo Fisher Scientific Recent Development

Table 85. F. Hoffmann-La Roche Ltd Corporation Information

Table 86. F. Hoffmann-La Roche Ltd Description and Business Overview

Table 87. F. Hoffmann-La Roche Ltd Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 88. F. Hoffmann-La Roche Ltd Cancer Biomarkers Product

Table 89. F. Hoffmann-La Roche Ltd Recent Development

Table 90. Illumina,Inc. Corporation Information

Table 91. Illumina,Inc. Description and Business Overview

Table 92. Illumina,Inc. Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 93. Illumina,Inc. Cancer Biomarkers Product

Table 94. Illumina,Inc. Recent Development

Table 95. Agilent Technologies Corporation Information

Table 96. Agilent Technologies Description and Business Overview

Table 97. Agilent Technologies Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 98. Agilent Technologies Cancer Biomarkers Product

Table 99. Agilent Technologies Recent Development

Table 100. Qiagen NV Corporation Information

Table 101. Qiagen NV Description and Business Overview

Table 102. Qiagen NV Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 103. Qiagen NV Cancer Biomarkers Product

Table 104. Qiagen NV Recent Development

Table 105. Merck & Co. Corporation Information

Table 106. Merck & Co. Description and Business Overview

Table 107. Merck & Co. Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 108. Merck & Co. Cancer Biomarkers Product

Table 109. Merck & Co. Recent Development

Table 110. Hologic,Inc. Corporation Information

Table 111. Hologic,Inc. Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 112. Hologic,Inc. Description and Business Overview

Table 113. Hologic,Inc. Cancer Biomarkers Product

Table 114. Hologic,Inc. Recent Development

Table 115. Novartis AG Corporation Information

Table 116. Novartis AG Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 117. Novartis AG Description and Business Overview

Table 118. Novartis AG Cancer Biomarkers Product

Table 119. Novartis AG Recent Development

Table 120. BioMerieux SA Corporation Information

Table 121. BioMerieux SA Description and Business Overview

Table 122. BioMerieux SA Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 123. BioMerieux SA Cancer Biomarkers Product

Table 124. BioMerieux SA Recent Development

Table 125. Genomic Health Corporation Information

Table 126. Genomic Health Description and Business Overview

Table 127. Genomic Health Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 128. Genomic Health Cancer Biomarkers Product

Table 129. Genomic Health Recent Development

Table 130. Affymetrix Corporation Information

Table 131. Affymetrix Description and Business Overview

Table 132. Affymetrix Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 133. Affymetrix Cancer Biomarkers Product

Table 134. Affymetrix Recent Development

Table 135. Roche Diagnostics Ltd. Corporation Information

Table 136. Roche Diagnostics Ltd. Description and Business Overview

Table 137. Roche Diagnostics Ltd. Cancer Biomarkers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 138. Roche Diagnostics Ltd. Cancer Biomarkers Product

Table 139. Roche Diagnostics Ltd. Recent Development

Table 140. Production Base and Market Concentration Rate of Raw Material

Table 141. Key Suppliers of Raw Materials

Table 142. Cancer Biomarkers Distributors List

Table 143. Cancer Biomarkers Customers List

Table 144. Market Key Trends

Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 146. Key Challenges

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Cancer Biomarkers Product Picture

Figure 2. Global Cancer Biomarkers Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Cancer Biomarkers Market Share by Application in 2020 & 2026

Figure 6. Breast Cancer Examples

Figure 7. Lung Cancer Examples

Figure 8. Colorectal Cancer Examples

Figure 9. Melanoma Examples

Figure 10. Blood Cancer Examples

Figure 11. Prostate Cancer Examples

Figure 12. Ovarian Cancer Examples

Figure 13. Stomach Cancer Examples

Figure 14. Liver Cancer Examples

Figure 15. Global Cancer Biomarkers Sales (K MT) Growth Rate (2015-2026)

Figure 16. Global Cancer Biomarkers Revenue (US$ Million) Growth Rate (2015-2026)

Figure 17. Global Cancer Biomarkers Price Trends Growth Rate (2015-2026) (USD/MT)

Figure 18. Global Cancer Biomarkers Revenue Market Share by Region: 2015 VS 2020

Figure 19. Global Cancer Biomarkers Revenue Market Share by Region: 2021 VS 2026

Figure 20. United States Cancer Biomarkers Revenue (Million USD) Growth Rate (2015-2026)

Figure 21. United States Cancer Biomarkers Sales (K MT) Growth Rate (2015-2026)

Figure 22. Europe Cancer Biomarkers Revenue (Million USD) Growth Rate (2015-2026)

Figure 23. Europe Cancer Biomarkers Sales (Million USD) Growth Rate (2015-2026)

Figure 24. China Cancer Biomarkers Revenue (Million USD) Growth Rate (2015-2026)

Figure 25. China Cancer Biomarkers Sales (Million USD) and Growth Rate (2015-2026)

Figure 26. Japan Cancer Biomarkers Revenue (Million USD) Growth Rate (2015-2026)

Figure 27. Japan Cancer Biomarkers Sales (Million USD) Growth Rate (2015-2026)

Figure 28. Southeast Asia Cancer Biomarkers Revenue (Million USD) Growth Rate (2015-2026)

Figure 29. Southeast Asia Cancer Biomarkers Sales (Million USD) Growth Rate (2015-2026)

Figure 30. India Cancer Biomarkers Revenue (Million USD) Growth Rate (2015-2026)

Figure 31. India Cancer Biomarkers Sales (Million USD) Growth Rate (2015-2026)

Figure 32. Global 5 Largest Cancer Biomarkers Players Market Share by Revenue in Cancer Biomarkers 2015 & 2019

Figure 33. Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 34. Global Cancer Biomarkers Revenue Share by Type (2015-2020)

Figure 35. Global Cancer Biomarkers Revenue Growth Rate by Type in 2015 & 2019

Figure 36. Global Cancer Biomarkers Revenue Share by Application (2015-2020)

Figure 37. Global Cancer Biomarkers Revenue Growth Rate by Application in 2015 & 2019

Figure 38. United States Cancer Biomarkers Sales Market Share by Type in 2019

Figure 39. United States Cancer Biomarkers Sales Market Share by Type in 2019

Figure 40. Europe Cancer Biomarkers Sales Market Share by Company in 2019

Figure 41. Europe Cancer Biomarkers Sales Market Share by Type in 2019

Figure 42. Europe Cancer Biomarkers Sales Market Share by Application in 2019

Figure 43. China Cancer Biomarkers Sales Market Share by Company in 2019

Figure 44. China Cancer Biomarkers Sales Market Share by Type in 2019

Figure 45. China Cancer Biomarkers Sales Market Share by Application in 2019

Figure 46. Japan Cancer Biomarkers Sales Market Share by Company in 2019

Figure 47. Japan Cancer Biomarkers Sales Market Share by Type in 2019

Figure 48. Japan Cancer Biomarkers Sales Market Share by Application in 2019

Figure 49. Southeast Asia Cancer Biomarkers Sales Market Share by Company in 2019

Figure 50. Southeast Asia Cancer Biomarkers Sales Market Share by Type in 2019

Figure 51. Southeast Asia Cancer Biomarkers Sales Market Share by Application in 2019

Figure 52. India Cancer Biomarkers Sales Market Share by Company in 2019

Figure 53. India Cancer Biomarkers Sales Market Share by Type in 2019

Figure 54. India Cancer Biomarkers Sales Market Share by Application in 2019

Figure 55. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018

Figure 57. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018

Figure 58. Illumina,Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 59. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018

Figure 60. Qiagen NV Total Revenue (US$ Million): 2019 Compared with 2018

Figure 61. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 62. Hologic,Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 63. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 64. BioMerieux SA Total Revenue (US$ Million): 2019 Compared with 2018

Figure 65. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018

Figure 66. Affymetrix Total Revenue (US$ Million): 2019 Compared with 2018

Figure 67. Roche Diagnostics Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 68. Key Raw Materials Price Trend

Figure 69. Manufacturing Cost Structure of Cancer Biomarkers

Figure 70. Manufacturing Process Analysis of Cancer Biomarkers

Figure 71. Cancer Biomarkers Industrial Chain Analysis

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles

Figure 74. Porter's Five Forces Analysis

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

---